PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
17/03/2026
Voltar para busca
Dado oficial do USPTO
NERVALIGN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
18/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
13/09/2018
Data de registro
12/11/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/11/2019
Última transação
18/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
82
Localização do titular
AU
Examinador
DEFORD, JEFFREY S
Localização atual
Historical data usage
Titulares e representantes
Titulares
RENERVE LIMITED
RENERVE PTY LTD
Representantes
Carrie A. Shufflebarger Thompson Hine LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Surgical dressings; surgical dressings being absorbable by the body; surgical dressings carrying substances to increase the rate of healing of the wounds; surgical dressings having absorbent qualities; surgical dressings incorporating collagen; surgical dressings made from collagen; surgical glues; surgical grafts comprising living tissues; surgical implants comprised of living tissues; surgical implants grown from stem cells and living tissues; tissues for surgical use
Classe 10
Apparatus for use in neuropathic and nerve repair surgery; clips for use in neuropathic and nerve repair surgery; electrical appliances for use in neuropathic and nerve repair surgery; electrically operated surgical apparatus for use in neuropathic and nerve repair surgery; electronic endoscopes for surgical use; endoscopes for surgical use; implantable materials for surgical use made by knitting synthetic yarn; infrared detection apparatus for surgical purposes; Synthetic non-living mesh nerve connecting tubes for surgical use; prostheses for handsfeetarms and legs for surgical treatment; surgical apparatus and instruments for use in neuropathic and nerve repair surgery; surgical graft materialssynthetic nerve tissue replacement and augmentation and nerve cuffs; surgical graftsartificial nerve grafts; surgical implantsnerve and dural implants made of artificial materials; surgical implants being artificial materials for use in guided tissue regeneration; surgical implants being artificial replacement materials for human tissue; surgical implants comprised of artificial materials; surgical instrumentation for use in neuropathic and nerve repair surgery; surgical membranes made of artificial materials; surgical nerve locator devices; surgical nerve stimulator devices; surgical prosthesesnerve and dural prostheses; surgical prostheses for human usenerve and dural prostheses; surgical prostheses for veterinary usenerve and dural prostheses; surgical suture materials; surgical transplant materialsartificial and synthetic nerve cuffsnerve graftsnerve conduitsnerve replacementsdural membrane overlays ; suture materials for surgical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/03/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/12/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
12/11/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/04/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/11/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/08/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
27/11/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/03/2020
FIMP
FINAL DISPOSITION PROCESSED
05/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/02/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
12/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/08/2019
PUBO
PUBLISHED FOR OPPOSITION
27/08/2019
GPNX
NOTIFICATION PROCESSED BY IB
23/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/08/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/08/2019
ALIE
ASSIGNED TO LIE
21/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/07/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/07/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/07/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/07/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/07/2019
RFNT
REFUSAL PROCESSED BY IB
02/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/01/2019
RFRR
REFUSAL PROCESSED BY MPU
11/01/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/12/2018
CNRT
NON-FINAL ACTION WRITTEN
24/12/2018
DOCK
ASSIGNED TO EXAMINER
22/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
13/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NERVALIGN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.